deltatrials
Completed PHASE1 NCT00063817

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Renal Allograft Tolerance Through Mixed Chimerism (ITN010ST)

Sponsor: Immune Tolerance Network (ITN)

Conditions End-stage Renal Disease Kidney Transplantation Renal Transplantation
Interventions Conditioning Regimen
Updated 7 times since 2017 Last updated: Dec 22, 2017 Started: Jun 30, 2003 Primary completion: Jan 31, 2009 Completion: Jul 31, 2009

A PHASE1 clinical study on End-stage Renal Disease and Kidney Transplantation, this trial is completed. The trial is conducted by Immune Tolerance Network (ITN) and has accumulated 7 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2018 — Jun 2018 [monthly]

    Completed PHASE1

▶ Show 2 earlier versions

  1. Feb 2017 — Jan 2018 [monthly]

    Completed PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Immune Tolerance Network (ITN)
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States